The OMERACT Emerging Leaders Program: The Good, the Bad, and the Future

Caroline A Flurey; Peter S Tugwell; Rachel J Black; Serena Halls; Matthew J Page; Joanna C Robson; Ilfita Sahbudin; Heidi J Siddle; Premarani Sinnathurai; Kathryn S Stok; Bethan Richards

doi:10.3899/jrheum.181126

The OMERACT Emerging Leaders Program: The Good, the Bad, and the Future

J Rheumatol. 2019 Aug;46(8):1047-1052. doi: 10.3899/jrheum.181126. Epub 2019 Mar 1.

Authors

Caroline A Flurey^{1

2}, Peter S Tugwell^{3

4}, Rachel J Black^{3

4}, Serena Halls^{3

4}, Matthew J Page^{3

4}, Joanna C Robson^{3

4}, Ilfita Sahbudin^{3

4}, Heidi J Siddle^{3

4}, Premarani Sinnathurai^{3

4}, Kathryn S Stok^{3

4}, Bethan Richards^{3

4}

Affiliations

¹ From the Faculty of Health and Applied Sciences, University of the West of England, Bristol; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Rheumatology Unit, Royal Adelaide Hospital, Adelaide; School of Public Health and Preventive Medicine, Monash University, Melbourne; Rheumatology Department, Royal North Shore Hospital; Sydney Medical School, University of Sydney, Sydney; Department of Biomedical Engineering, The University of Melbourne, Victoria, Australia. Caroline2.Flurey@uwe.ac.uk.
² C.A. Flurey, MSc, PhD, CPsychol, FHEA, Faculty of Health and Applied Sciences, University of the West of England; P.S. Tugwell, MD, MSc, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; R.J. Black, MBBS, FRACP, Rheumatology Unit, Royal Adelaide Hospital; S. Halls, MSc, PhD, Faculty of Health and Applied Sciences, University of the West of England; M.J. Page, BBSc (Hons), PhD, School of Public Health and Preventive Medicine, Monash University; J.C. Robson, BSc, PhD, MRCP, Faculty of Health and Applied Sciences, University of the West of England; I. Sahbudin, BM, MSc, MRCP, Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham; H.J. Siddle, BSc (Hons), MSc, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; P. Sinnathurai, BSc (Med), MBBS, FRACP, Rheumatology Department, Royal North Shore Hospital, and Sydney Medical School, University of Sydney; K.S. Stok, PhD, Department of Biomedical Engineering, The University of Melbourne; B. Richards, MBBS (Hons), MSc, Department of Rheumatology, Royal Prince Alfred Hospital, and Sydney Medical School, University of Sydney. Caroline2.Flurey@uwe.ac.uk.
³ From the Faculty of Health and Applied Sciences, University of the West of England, Bristol; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK; Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; Rheumatology Unit, Royal Adelaide Hospital, Adelaide; School of Public Health and Preventive Medicine, Monash University, Melbourne; Rheumatology Department, Royal North Shore Hospital; Sydney Medical School, University of Sydney, Sydney; Department of Biomedical Engineering, The University of Melbourne, Victoria, Australia.
⁴ C.A. Flurey, MSc, PhD, CPsychol, FHEA, Faculty of Health and Applied Sciences, University of the West of England; P.S. Tugwell, MD, MSc, FRCPC, Division of Rheumatology, Department of Medicine, and School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, and Clinical Epidemiology Program, Ottawa Hospital Research Institute; R.J. Black, MBBS, FRACP, Rheumatology Unit, Royal Adelaide Hospital; S. Halls, MSc, PhD, Faculty of Health and Applied Sciences, University of the West of England; M.J. Page, BBSc (Hons), PhD, School of Public Health and Preventive Medicine, Monash University; J.C. Robson, BSc, PhD, MRCP, Faculty of Health and Applied Sciences, University of the West of England; I. Sahbudin, BM, MSc, MRCP, Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham; H.J. Siddle, BSc (Hons), MSc, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; P. Sinnathurai, BSc (Med), MBBS, FRACP, Rheumatology Department, Royal North Shore Hospital, and Sydney Medical School, University of Sydney; K.S. Stok, PhD, Department of Biomedical Engineering, The University of Melbourne; B. Richards, MBBS (Hons), MSc, Department of Rheumatology, Royal Prince Alfred Hospital, and Sydney Medical School, University of Sydney.

PMID: 30824659
DOI: 10.3899/jrheum.181126

Abstract

Objective: To describe the experience of the first OMERACT Emerging Leaders Program (ELP).

Methods: A Delphi process identified positive aspects, areas for improvement, and future directions. Core items were defined as essential if they received ≥ 70% ratings.

Results: Participants valued relatable/accessible mentors (100%), including an OMERACT Executive mentor (100%), and a support network of peers (90%). Key items for future development were funding support (100%) and developing knowledge about OMERACT processes (90%) and politics (80%).

Conclusion: The ELP has the potential to provide targeted training for early career researchers to develop relevant skills for future leadership roles within OMERACT.

Keywords: CAREER DEVELOPMENT; EARLY CAREER RESEARCHERS; EDUCATION; EMERGING LEADERS; OMERACT; OUTCOMES.

MeSH terms

Career Mobility*
Humans
Leadership*
Mentors*
Rheumatologists*

Abstract

MeSH terms

Grants and funding